Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalya Gankina"'
Autor:
Vasily Isakov, Charlotte Hedskog, Joel O. Wertheim, Reilly E. Hostager, Bandita Parhy, Adriano De Bernardi Schneider, Vithika Suri, Hongmei Mo, Natalia Geivandova, Vyacheslav Morozov, Elena Bessonova, Natalya Gankina, Konstantin Zhdanov, Dzhamal Abdurakhmanov, Evguenia Svarovskaia
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 36-42 (2021)
Objectives: Due to limited hepatitis C virus (HCV) sequence availability from patients in Russia, the relationship between subtypes and baseline resistance-associated substitutions (RAS) to direct antiretroviral treatment outcome is not fully underst
Externí odkaz:
https://doaj.org/article/62204307acfa4b22ac5731f4fecfea42
Autor:
Natalia Geivandova, K. V. Zhdanov, Natalya Gankina, Adriano de Bernardi Schneider, Hongmei Mo, Bandita Parhy, Reilly Hostager, Vyacheslav Morozov, Vithika Suri, D.T. Abdurakhmanov, Charlotte Hedskog, Vasily Isakov, Joel O. Wertheim, Elena Bessonova, Evguenia S. Svarovskaia
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss, Pp 36-42 (2021)
Objectives Due to limited hepatitis C virus (HCV) sequence availability from patients in Russia, the relationship between subtypes and baseline resistance-associated substitutions (RAS) to direct antiretroviral treatment outcome is not fully understo
Autor:
Ploenchan Chetchotisakd, Cissy Kityo, Khuanchai Supparatpinyo, Anchalee Avihingsanon, Evgeny Voronin, Tariro Makadzange, Huyen Cao, Jeffrey L. Stephens, Rima Acosta, Edwin DeJesus, Vadim Pokrovsky, Natalya Gankina, Erin Quirk, Ellen Koenig, Hal Martin, Hui Wang, Debbie Hagins
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 82(3), 321-328. Lippincott Williams and Wilkins
BACKGROUND: Bictegravir, coformulated with emtricitabine/tenofovir alafenamide as a fixed-dose combination (B/F/TAF), is recommended for treatment of HIV-1-infection. Multiple studies of B/F/TAF in treatment-naive and virologically suppressed cohorts
Autor:
Diana M. Brainard, Vladimir Ivashkin, Elena Nurmukhametova, K. V. Zhdanov, John McNally, D.T. Abdurakhmanov, Ola Weiland, Evguenia S. Svarovskaia, Eduard Burnevich, Martin Lagging, Sergey V. Zhuravel, Svetlana Romanova, Galina Kozhevnikova, Igor G. Bakulin, Vasily Isakov, Robert H. Hyland, Vladimir Chulanov, Vyacheslav Morozov, Sophia Lu, Natalya Gankina
Publikováno v:
Infectious diseases (London, England). 51(2)
In both Russia and Sweden, the dominant hepatitis C virus (HCV) is genotype 1, but around one-third of patients have genotype 3 infection. For such countries, HCV genotype testing is recommended prior to therapy. An effective pangenotypic therapy may
Autor:
Natalya Gankina, Charlotte Hedskog, Hongmei Mo, Anuj Gaggar, K. V. Zhdanov, Natalia Geivandova, Joel O. Wertheim, Morozov Viacheslav, Vasily Isakov, Elena Bessonova, Evguenia S. Svarovskaia
Publikováno v:
Journal of Hepatology. 70:e703-e704